news
NeuroCOVID will be a resource of clinical information and biospecimens…
28 January 2021 | By Hannah Balfour (Drug Target Review)
NeuroCOVID will be a resource of clinical information and biospecimens from people who experience neurological problems associated with SARS-CoV-2 infection.